IMAGENEBIO INC

Insider buying surge at ImageneBio signals bullish outlook—large option purchases, low price, high buzz hint at potential upside.

Insightful look at ImageneBio’s insider buying, showing how Bonita David P’s large warrant purchases signal confidence while hinting at potential dilution risks for investors.

CEO Yarema Kristin’s recent bulk purchase of ImageneBio shares signals strong insider confidence amid leadership shake‑ups, hinting at a potential turnaround in its oncology pipeline.